Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has decreased the efficacy of SARS-CoV-2 vaccines in containing coronavirus disease 2019 (COVID-19) over time, and booster vaccination strategies are urgently necessitated to achieve sufficient protection. Intrana...

Full description

Bibliographic Details
Main Authors:	Li Chen, Wenyan Ren, Hong Lei, Jiayu Wang, Haiying Que, Dandan Wan, Aqu Alu, Dandan Peng, Minyang Fu, Weiqi Hong, Yuhe Huang, Xiangrong Song, Guangwen Lu, Xiawei Wei
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2024-07-01
Series:	Genes and Diseases
Subjects:	Heterologous immunization Intranasal immunization mRNA vaccine SARS-CoV-2 Subunit protein vaccine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223003483

Similar Items

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
by: Shaswath S. Chandrasekar, et al.
Published: (2023-01-01)

Intranasal delivery of RIG-I agonist drives pulmonary myeloid cell activation in mice
by: Nair, Sajith, et al.
Published: (2022)

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
by: Tuksin Jearanaiwitayakul, et al.
Published: (2021-07-01)

Early Activation of the Innate Immunity and Specific Cellular Immune Pathways after Vaccination with a Live Intranasal Viral Vaccine and Challenge with Bovine Parainfluenza Type 3 Virus
by: Piet Nuijten, et al.
Published: (2022-01-01)

Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors
by: Gloria Sierra, et al.
Published: (2020-05-01)

A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants
by: Weiqi Hong, et al.
Published: (2024-05-01)

A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice
by: Bhawana Pandey, et al.
Published: (2024-12-01)

Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines
by: Patricia A. Boley, et al.
Published: (2023-02-01)

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
by: Sybil Tasker, et al.
Published: (2021-03-01)

Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial
by: Mohammad Hossein Fallah Mehrabadi, et al.
Published: (2024-11-01)

Intranasal delivery of a recombinant adenovirus vaccine encoding the PEDV COE elicits potent mucosal and systemic antibody responses in mice
by: Shijie Yan, et al.
Published: (2024-10-01)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
by: Xiaoyi Gao, et al.
Published: (2021-12-01)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
by: Kuldeep Dhama, et al.
Published: (2022-11-01)

A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens
by: Panli Zhang, et al.
Published: (2023-12-01)

Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus
by: R. Garg, et al.
Published: (2017-12-01)

Tuberculosis Vaccines and T Cell Immune Memory
by: Fei Li, et al.
Published: (2024-04-01)

A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
by: Danyi Ao, et al.
Published: (2025-03-01)

Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants
by: Xuesong Xu, et al.
Published: (2022-12-01)

Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges
by: Chi-Hsun Chen, et al.
Published: (2022-05-01)

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
by: Wen-Hsiang Chen, et al.
Published: (2020-06-01)

Surgical Primary Tumor Resection Reduces Accumulation of CD11b<sup>+</sup> Myeloid Cells in the Lungs Augmenting the Efficacy of an Intranasal Cancer Vaccination against Secondary Lung Metastasis
by: Michael Donkor, et al.
Published: (2023-12-01)

Intranasal immunization with a Bucl8-based vaccine ameliorates bacterial burden and pathological inflammation, and promotes an IgG2a/b dominant response in an outbred mouse model of Burkholderia infection
by: Megan Grund, et al.
Published: (2023-07-01)

Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines
by: Hui Wu, et al.
Published: (2017-06-01)

Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
by: Evgeny B. Faizuloev, et al.
Published: (2024-03-01)

Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease
by: Seok-Chan Park, et al.
Published: (2023-07-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
by: Kaori Sano, et al.
Published: (2018-08-01)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
by: Giulia Perego, et al.
Published: (2021-09-01)

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
by: William R. Lykins, et al.
Published: (2024-12-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
by: Vidthiya Jeyanathan, et al.
Published: (2022-06-01)

Vaccination strategies, the power of the unmatched double hits
by: Talal S Al-Qaisi, et al.
Published: (2023-10-01)

Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
by: Masoud Solaymani Dodaran, et al.
Published: (2023-02-01)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
by: Vidthiya Jeyanathan, et al.
Published: (2023-02-01)

Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge
by: Nisha Kannan, et al.
Published: (2024-06-01)

Duration of Immunity in Cattle to Lumpy Skin Disease Utilizing a Sheep Pox Vaccine
by: Varduhi Hakobyan, et al.
Published: (2024-04-01)

Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
by: Junhu Tai, et al.
Published: (2022-05-01)

Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes
by: Mana Mahapatra, et al.
Published: (2020-04-01)

Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
by: Shaswath S. Chandrasekar, et al.
Published: (2021-02-01)

Enhanced Systemic and Mucosal Immune Responses to <i>Haemophilus parasuis</i> by Intranasal Administration of Lactic-Co-Glycolic Acid Microspheres
by: Tianyu Lei, et al.
Published: (2024-09-01)

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
by: Mark Aninakwah Asante, et al.
Published: (2024-06-01)